secwatch.observer — SEC 8-K summary
======================================

Issuer:     EKSO BIONICS HOLDINGS, INC. (CHRN)
CIK:        0001549084
Form:       8-K
Filed at:   2022-12-09T23:59:59+00:00
Accession:  0001549084-22-000080
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Ekso Bionics appoints CEO Scott G. Davis to its Board of Directors
------------------------------------------------------------------

- Appointment effective Dec 8, 2022; term expires at 2023 Annual Meeting.
- Davis previously served as President and COO before becoming CEO.
- No arrangements or understandings with any person for his board election.
- No family relationships or material interest in reportable transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1549084/000154908422000080/0001549084-22-000080-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1549084/000154908422000080/ekso-20221208.htm
  HTML page:      https://secwatch.observer/filing/0001549084-22-000080

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer